NCT02224703View on ClinicalTrials.gov

GWPCARE2 A Study to Investigate the Efficacy and Safety of Cannabidiol (GWP42003-P) in Children and Young Adults With Dravet Syndrome

PHASE3CompletedINTERVENTIONAL
Enrollment

199

Participants

Timeline

Start Date

April 13, 2015

Primary Completion Date

April 9, 2018

Study Completion Date

April 9, 2018

Conditions
EpilepsyDravet Syndrome
Interventions
DRUG

GWP42003-P

DRUG

Placebo Control

Trial Locations (38)

3084

Heidelberg

14203

Buffalo

27599

Chapel Hill

28009

Madrid

28034

Madrid

28222

Madrid

29425

Charleston

31008

Pamplona

31404

Savannah

33155

Miami

35233

Birmingham

40202

Louisville

41013

Seville

46026

Valencia

52621

Ramat Gan

55102

Saint Paul

60611

Chicago

63141

St Louis

68106

Omaha

72202

Little Rock

76104

Fort Worth

78723

Austin

90027

Los Angeles

95816

Sacramento

97239

Portland

98105

Seattle

06106

Hartford

40536-0284

Lexington

03756

Lebanon

19104-4399

Philadelphia

23298-0211

Richmond

NSW 2031

Randwick

5591 VE

Heeze

8025 BV

Zwolle

30-363

Krakow

93-271

Lodz

04-730

Warsaw

08022

Barcelona

Sponsors
All Listed Sponsors
lead

Jazz Pharmaceuticals

INDUSTRY